Evidence map›Paper›PMID 39987380›Full record

ArticleCommunications biology2025

Characterization of a second class Ie ribonucleotide reductase.

Juliane John, Daniel Lundin, Rui M Branca, Rohit Kumar, Vivek Srinivas, Hugo Lebrette, Martin Högbom

Erratum issuedAbstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Juliane JohnDepartment of Biochemistry and Biophysics, Stockholm University, Arrhenius Laboratories for Natural Sciences, Stockholm, Sweden.
Daniel LundinDepartment of Biochemistry and Biophysics, Stockholm University, Arrhenius Laboratories for Natural Sciences, Stockholm, Sweden.
Rui M BrancaCancer Proteomics Mass Spectrometry, Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.ORCID http://orcid.org/0000-0003-3890-6476
Rohit KumarDepartment of Biochemistry and Biophysics, Stockholm University, Arrhenius Laboratories for Natural Sciences, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-5033-2810
Vivek SrinivasDepartment of Biochemistry and Biophysics, Stockholm University, Arrhenius Laboratories for Natural Sciences, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-0265-1873
Hugo LebretteLaboratoire de Microbiologie et Génétique Moléculaires, Centre de Biologie Intégrative, CNRS - University of Toulouse, Toulouse, France. hugo.lebrette@univ-tlse3.fr.ORCID http://orcid.org/0000-0002-8081-181X
Martin HögbomDepartment of Biochemistry and Biophysics, Stockholm University, Arrhenius Laboratories for Natural Sciences, Stockholm, Sweden. hogbom@dbb.su.se.ORCID http://orcid.org/0000-0001-5574-9383

Funding

Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) 2017.0275Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) 2019.0436Vetenskapsrådet (Swedish Research Council) 2019-01400Vetenskapsrådet (Swedish Research Council) 2021-03992
6 · The paper itself

Abstract

Class I ribonucleotide reductases (RNRs) convert ribonucleotides into deoxyribonucleotides under oxic conditions. The R2 subunit provides a radical required for catalysis conducted by the R1 subunit. In most R2s the radical is generated on a tyrosine via oxidation by an adjacent metal site. The discovery of a metal-free R2 defined the new RNR subclass Ie. In R2e, three of the otherwise strictly conserved metal-binding glutamates in the active site are substituted. Two variants have been found, VPK and QSK. To date, the VPK version has been the focus of biochemical characterization. Here we characterize a QSK variant of R2e. We analyse the organismal distribution of the two R2e versions and find dozens of organisms relying solely on the QSK RNR for deoxyribonucleotide production. We demonstrate that the R2e

Indexed as

Bacterial ProteinsRibonucleotide ReductasesCatalytic DomainRibonucleotidesBacterial ProteinsRibonucleotide ReductasesRibonucleotides

Identifiers

PMID39987380
PMCPMC11846895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.